Panoramic Health
Panoramic Health Launches Clinical Research Division to Drive Discovery of Novel Kidney Disease Therapies
26 oct. 2022 08h00 HE | Panoramic Health
TEMPE, Ariz., Oct. 26, 2022 (GLOBE NEWSWIRE) -- Today, Panoramic Health℠, the nation's leading integrated value-based kidney care platform, announced the launch of its clinical research division...
AHN Full Logo.JPG
Africa Healthcare Network names Matt Williams as new CEO, as Co-Founder Nikhil Pereira Transitions to Executive Chairman
01 juil. 2022 01h00 HE | Africa Healthcare Network
NAIROBI, Kenya, July 01, 2022 (GLOBE NEWSWIRE) -- Africa Healthcare Network (“AHN”), East Africa’s largest kidney care and dialysis provider across Kenya, Tanzania and Rwanda, today announced that...
chf.jpg
CHF Solutions and RenalSense Enter Distribution Partnership to Offer Ultrafiltration and Real-Time Renal Diagnostics
08 juil. 2020 09h25 HE | CHF Solutions, Inc.
EDEN PRAIRIE, Minn., July 08, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS) and RenalSense, Ltd., today announced the signing of a distribution agreement to offer complementary solutions for...
New Proteon Logo - full color RGB.jpg
Proteon Therapeutics Announces Third Quarter 2019 Financial Results
31 oct. 2019 17h00 HE | Proteon Therapeutics, Inc.
WALTHAM, Mass., Oct. 31, 2019 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (“Proteon” or the “Company”) (Nasdaq: PRTO), a company that has historically focused on the development of novel,...
New Proteon Logo - full color RGB.jpg
Proteon Therapeutics and ArTara Therapeutics Agree to Combine
23 sept. 2019 16h20 HE | Proteon Therapeutics, Inc.
Transaction to Create NASDAQ-Listed Rare and Specialty Disease Therapeutic Company Focused on Immunology and Metabolic Disorders $42.5M Concurrent Financing to be Led by a Syndicate of Healthcare...
New Proteon Logo - full color RGB.jpg
Proteon Therapeutics Announces Second Quarter 2019 Financial Results
07 août 2019 08h00 HE | Proteon Therapeutics, Inc.
WALTHAM, Mass., Aug. 07, 2019 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq: PRTO), a company that has historically focused on the development of novel, first-in-class pharmaceuticals to...
gmi 2018.png
Worldwide Stent Market value worth $16 billion by 2025: Global Market Insights, Inc.
10 juin 2019 04h42 HE | Global Market Insights, Inc
Selbyville, Delaware, June 10, 2019 (GLOBE NEWSWIRE) -- Bioresorbable stent market will grow at 7.8% over the projected period. Bioresorbable stents get absorbed in the body after serving its...
New Proteon Logo - full color RGB.jpg
Proteon Therapeutics Announces First Quarter 2019 Financial Results
08 mai 2019 08h00 HE | Proteon Therapeutics, Inc.
WALTHAM, Mass., May 08, 2019 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq: PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with...
New Proteon Logo - full color RGB.jpg
Proteon Therapeutics Announces Review of Potential Strategic Transactions
15 avr. 2019 16h30 HE | Proteon Therapeutics, Inc.
WALTHAM, Mass., April 15, 2019 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq: PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with...
New Proteon Logo - full color RGB.jpg
Proteon Therapeutics Announces Top-Line Results From Phase 3 PATENCY-2 Clinical Trial of Vonapanitase in Radiocephalic Arteriovenous Fistulas
28 mars 2019 08h00 HE | Proteon Therapeutics, Inc.
WALTHAM, Mass., March 28, 2019 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq: PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with...